The modification of lactoferrin and the adsorption of endogenous albumin have a dual-targeting effect on the receptors of both LRP1 and Secreted protein acidic and rich in cysteine (SPARC), which are overexpressed in tumor cells and immune cells. The gene discussed is LTF; the disease is neoplasm.